Applications published 6 May 2009
Subcutaneous implants releasing an active principle over an extended period of time
Mediolanum Pharmaceuticals 2054028*
Subcutaneous implants releasing an active principle over an extended period of time
Mediolanum Pharmaceuticals 2054029*
Antimicrobials
UCLÃ ‚ Business 2054030*
Transmucosal delivery devices with enhanced uptake
Biodelivery Sciences 2054031*
Flowable carrier matrix
Warsaw Orthopaedic 2054032*
Liquid preparation
Asubio Pharma 2054033*
Aerosol formulation comprising beta-agonists and steroids
Boehringer Ingelheim International 2054034*
Nanoliposome using esterified lecithin and method for preparing the same, and compsns for preventing or treating skin diseases comprising the same
Daewoong 2054035*
Solid nanoparticle formulation of water insoluble pharmaceutical substances with reduced ostwald ripening
Singh-Broemer and Company 2054036*
Subcutaneous implants releasing an active principle over an extended period of time
Mediolanum Pharmaceuticals 2054037*
Solid dosage form
Arrow International 2054038*
Viscoelastic aqueous gels comprising microspheres
OctoPlus Sciences 2054039*
Method for making solid dispersions of highly crystalline therapeutic dispersions
Novartis; Novartis Pharma 2054040*
Formulations of flibanserin and method for manufacturing the same
Boehringer Ingelheim International 2054041*
Methods for the preparation of biologically active compounds in nanoparticulate form
Iceutica 2054042*
Nanoparticle compsns
Novartis; Novartis Pharma 2054043*
Medicament for LCTÃ ‚ poisoning
Johannes Gutenberg-Universitaet Mainz 2054044*
Use of 2,5-dihydroxybenzene derivatives for the treatment of arthritis and pain
Action Medicines 2054045*
Compsns containing chalcones and uses thereof
Johnson and Johnson Consumer Care 2054046*
Methods for treating acute acoustic trauma
Hough Ear Institute 2054047*
Novel salts of the active substance rasagiline
Ratiopharm 2054048*
Substituted acylanilides and methods of use thereof
University of Tennessee Research Foundation 2054049*
Treatment of cartilage disorders with FGF-18
Ares Trading 2054050*
Use of 2,5-dihydroxybenzene derivatives for treating actinic keratosis
Action Medicines 2054051*
Drug combination pharmaceutical compsns and methods for using them
Vicus Therapeutics 2054052*
Biphenyl substituted spirotetronic acids and their use for the treatment of retroviral disorders
AiCuris 2054053*
Use of azabicyclo hexane derivatives
Glaxo Group 2054054*
Combination FAAH inhibitor and analgesic, anti-inflammatory or anti-pyretic agent
Organon 2054055*
Small molecule inhibitors of kynurenine-3-monooxygenase
The Gladstone Institutes, A Testamentary Trust Established under the will of David Gladstone 2054056*
Combination andolast/glucocorticoids
Rottapharm 2054057*
Inhibitors of pyruvate kinase and methods of treating disease
Beth Israel Deaconess Medical Centre 2054058*
Triazole compounds that modulate HSP90 activity
Synta Pharmaceuticals 2054059*
Fluorinated ligands for targeting peripheral benzodiazepine
Australian Nuclear Science and Technology Organisation 2054060*
Combination therapy
Ariad Gene Therapeutics 2054061*
Use of HPPDÃ ‚ inhibitors in the treatment of depression and/or withdrawal symptoms associated with addictive drugs
Syngenta 2054062*
4-aminoquinazoline derivatives and methods of use thereof
Concert Pharmaceuticals 2054063*
Transdermal application of triazines for controlling coccidia infections
Bayer Animal Health 2054064*
Methods, uses and compsns for modulating replication of HCVÃ ‚ through the farnesoid XÃ ‚ receptor (FXR)Ã ‚ activation of inhibition
INSERMÃ ‚ (Institut National de la Sante et de la Recherche Medicale) 2054065*
Methods for treatment of radiation enteritis
Salix Pharmaceuticals 2054066*
Administration of high potency platinum compound formulations by inhalation
Transave 2054067*
Methods and compsns for removing cells from collection material
Orchid Cellmark 2054068*
Use of a Gingko biloba extract for the treatment of mitochondrial diseases of genetic origin
Ipsen Pharma 2054069*
A novel herbal drug and a process for preparation thereof for the prevention and management of endothelial dysfunction among type-IIÃ ‚ diabetes mellitus cases
Swaminathan, S 2054070*
Process for preparing a compsn comprising steroidal glycosides
Unilever 2054071*
Heat processed vegtabilic fibre preparation and its use as inhibitor of the effects of carcinogenic substances in humans or animals
Essentys 2054072*
Pharmaceutical compsns for sustained release delivery of peptides
QPS 2054073*
Modified erythropoietin
Prolong Pharmaceuticals 2054074*
Treatment of graft-versus-host disease
Zymogenetics 2054075*
Combination therapy for treatment of viral infections
United Therapeutics Corp 2054076*
Polypeptide derivatives of parathyroid hormone (PTH)
The General Hospital Corp 2054077*
Long-lasting absorption of flavonoids
Nestec 2054078*
Compsns for reprogramming a cell and uses therefor
University of Florida 2054079*
Treatment and prevention of allergic airways diseases
Newcastle Innovation 2054080*
JC virus vaccine
Baylor Research Institute 2054081*
Therapeutic methods for treating vascular eye disorders with DLL4 antagonists
Regeneron Pharmaceuticals 2054083*
A pharmaceutical compsn for treating cholangiocarcinoma, a method for inhibiting growth or invasion of cholangiocarcinoma and a method for treating cholangiocarcinoma
Korea Research Institute of Bioscience and Technology 2054083*
Aerosol formulation for the inhalation of beta agonists
Boehringer Ingelheim International; Boehringer Ingelheim Pharma 2054084*
Nanoparticle nucleic acid bonding compound conjugates forming I-motifs
Roche Diagnostics 2054085*
A conjugate of an antibody against CCR5 and an antifusogenic peptide
FÃ ‚ Hoffmann-La Roche 2054086*
Polychromatic, diversely-sized particles for angiography
The Trustees of Columbia University of the City of New York 2054087*
Process for the preparation of sodium salt of ibuprofen of different particle sizes
Albemarle Corp 2054367*
Cyclic 11-beta hydroxysteroid dehydrogenase type 1 inhibitors
Bristol-Myers Squibb 2054368*
Process and apparatus for preparing alkyl esters of metacrylic acid
Evonik Roehm 2054369*
Integrated process and apparatus for preparing esters of methacrylic acid from acetone and hydrocyanic acid
Evonik Roehm 2054370*
Crystalline tolterodine tartarate and a pharmaceutical compsn containing the same
Zentiva 2054372*
Improved process for the preparation of rivastigmine
Alembic 2054373*
Novel hydrate form of O-des-methyl venlafaxine succinate
Generics (UK); Merck Development Centre Private 2054374*
Process of preparing a gamma-amino acid
Generics (UK); Merck Development Centre Private 2054375*
Process for preparing carboxamides by hydrolysis of carboxylic acid nitriles in the presence of a catalyst comprising manganese dioxide
Evonik Roehm 2054376*
Chemical compounds
Praecis Pharmaceuticals 2054377*
Process for preparing cyanohydrins and their use in the preparation of alkyl esters of methacrylic acid
Evonik Roehm 2054378*
An improved proces for the preparation of entacapone
Alembic 2054379*
Trypsin-like serine protease inhibitors and their preparation and use
The Medicines Company (Leipzig) 2054380*
Pharmacodynamic hybrids endowed of hypoglycemic and no-donor activities obtained combining hydroxylated derivatives of glibenclamide and nitrooxy-substituted carboxylic acids
Universita" di Pisa 2054381*
Method for the production of D,L-2-hydroxy-4-alkylthio butyric acid
Evonik Degussa 2054382*
Novel compounds as antagonists or inverse agonists at opioid receptors
SmithKline Beecham 2054383*
Positively charged water-soluble prodrugs or aryl- and heteropropionic acids with very fast skin preparation rate
Techfields Biochem 2054384*
Phenyl, pyridine and quinoline derivatives
F Hoffmann-La Roche 2054385*
Non-flushing niacin analogues and methods of use thereof
Trustees of Tufts College 2054386*
Process for the manufacture of hi-6 dimethanesulphonate
Phoenic Chemicals 2054387*
Viral polymerase inhibitors
Boehringer Ingelheim International; Boehringer Ingelheim Pharma 2054388*
6-substituted isoquinoline derivatives as rock-1 inhibitors
Organon 2054389*
Indazole derivatives that inhibit TRPV1 and uses thereof
Abbott Laboratories 2054390*
Crystalline moxonidine comprising single tautomer and preparation process therefor
Chemagis 2054391*
2-anilino-4-(heterocyclic)amino-pyrimidines as inhibitors of protein kinase C-alpha
Boehringer Ingelheim International; Boehringer Ingelheim Pharma 2054392*
Crystalline ertlotinib
Synthon 2054393*
A process for the preparation of lamotrigine
Lonza 2054396*
Small molecule inhibitors of kynurenine-3-monooxygenase
The David Gladstone Institutes, A Testamentary Trust Established under the Will of David Gladstone; University of Maryland 2054397*
New heterocyclic compounds containing nitrogen atoms or pharmaceutically acceptable salts thereof, process for the preparation thereof and pharmaceutical compsn comprising the same for treatment of cancer
Korea Research Institute of Bioscience and Biotechnology; Seoul Pharm 2054398*
